Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers

Gemcitabine chemotherapy has been the standard for advanced pancreatic cancer for more than a decade. New oral fluoropyrimidines such as S-1 and capecitabine are other key drugs. Gemcitabine plus erlotinib was the only combination therapy that significantly prolonged survival, although the effect wa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tada, Minoru, Nakai, Yousuke, Sasaki, Takashi, Hamada, Tsuyoshi, Nagano, Rie, Mohri, Dai, Miyabayashi, Koji, Yamamoto, Keisuke, Kogure, Hirofumi, Kawakubo, Kazumichi, Ito, Yukiko, Yamamoto, Natsuyo, Sasahira, Naoki, Hirano, Kenji, Ijichi, Hideaki, Tateishi, Keishuke, Isayama, Hiroyuki, Omata, Masao, Koike, Kazuhiko
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2011
Assuntos:
Topic Highlight
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3100481/
https://ncbi.nlm.nih.gov/pubmed/21611090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v2.i3.158
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados